drugset / Trial / NCT01448018

Hemodilution Versus Ranibizumab in Early-onset Central Retinal Vein Occlusion

NCT01448018

Phase 4 Completed 45 enrolled Centre Hospitalier Intercommunal Creteil
RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study is to compare ranibizumab injection to hemodilution at the early phase of Central Retinal Vein Occlusion (CRVO) and to determine if the combination of both treatments may have a synergic effect.

Timeline

Start
2010-01
Primary completion
2013-06
Completion
2013-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator Ranibizumab Monoclonal antibody Intravitreal